National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2016 (No. 1) (PB 6 of 2016) (Cth)

PB 6 of 2016

National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2016 (No. 1)

National Health Act 1953

___________________________________________________________________________

I, Tony Wynd, Acting Assistant Secretary, Pharmaceutical Access Branch, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated 29 January 2016

TONY WYND

Acting Assistant Secretary

Pharmaceutical Access Branch

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________

1              Name of Instrument

(1)This Instrument is the National Health (Efficient Funding of Chemotherapy) Special Arrangement Amendment Instrument 2016 (No. 1).

(2)This Instrument may also be cited as PB 6 of 2016.

2             Commencement

This Instrument commences on 1 February 2016.

3              Amendments to PB 79 of 2011

Amends the National Health (Efficient Funding of Chemotherapy) Special Arrangement 2011 (PB 79 of 2011).

Amendments

1. Schedule 1 Part 1 entry for Docetaxel:

omit:

Solution concentrate for I.V. infusion 20 mg in 1 mL Injection Taxotere SW MP D

1. Schedule 1 Part 1 entry for Docetaxel in the form Solution concentrate for I.V. infusion 80 mg in 4 mL:

omit:

Taxotere SW MP D

1. Schedule 1 Part 1 entry for Oxaliplatin in each of the forms Solution concentrate for I.V. infusion 100 mg in 20 mL; Solution concentrate for I.V. infusion 200 mg in 40 mL; Solution concentrate for I.V. infusion 50 mg in 10 mL:

omit:

Eloxatin SW MP D

1. Schedule 1 Part 1 entry for Pemetrexed:

substitute:

Pemetrexed	Powder for I.V. infusion 100 mg (as disodium heptahydrate)	Injection	Alimta	LY	MP	C4789 C4792	D
			DBL Pemetrexed	HH	MP	C4789 C4792	D
			Pemetrexed APOTEX	TX	MP	C4789 C4792	D
			Pemetrexed Juno	JU	MP	C4789 C4792	D
			Pemetrexed MYX	YN	MP	C4789 C4792	D
			Reladdin	AF	MP	C4789 C4792	D
	Powder for I.V. infusion 500 mg (as disodium heptahydrate)	Injection	Alimta	LY	MP	C4789 C4792	D
			DBL Pemetrexed	HH	MP	C4789 C4792	D
			Pemetrexed APOTEX	TX	MP	C4789 C4792	D
			Pemetrexed DRLA	RZ	MP	C4789 C4792	D
			Pemetrexed Juno	JU	MP	C4789 C4792	D
			Pemetrexed MYX	YN	MP	C4789 C4792	D
			Pemetrexed Sandoz	SZ	MP	C4789 C4792	D
			Reladdin	AF	MP	C4789 C4792	D

1. Schedule 3 after entry for JC:

insert:

JU Juno Pharmaceuticals Pty Ltd 55 156 303 650